A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: Update VIII 2008 to 2010

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 11, 2011, Pages 1310-1331

  Pelletier, Kenneth R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; EXPERIMENTAL STUDY; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH HAZARD; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LOW BACK PAIN; LUPUS ERYTHEMATOSUS NEPHRITIS; METABOLIC SYNDROME X; OBESITY; OCCUPATIONAL HEALTH; OUTCOME ASSESSMENT; PREVENTIVE MEDICINE; QUASI EXPERIMENTAL STUDY; REVIEW; SMOKING CESSATION; SYSTEMIC LUPUS ERYTHEMATOSUS; WORK ENVIRONMENT;

LEXIS;

EID: 81155128645     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3182337748     Document Type: Article

References (87)

1. Aldana SG, Merril RM, Price K, Hardy A, Hager R. Financial impact of a comprehensive multisite workplace health promotion program. Prev Med. 2005;40:131-137. (Pubitemid 39468603)
2. Alderman MH, Schoenbaum EE. Detection and treatment of hypertension at the work site. N Engl J Med. 1975;2:65-68.
3. Baker KM, Goetzel RZ, Pei X, et al. Using a return-on-investment estimation model to evaluate outcomes from an obesity management worksite health promotion program. J Occup Environ Med. 2008;50:981-986.
4. Bauer RL, Heller RF, Challah S. United Kingdom Heart Disease Prevention Project: 12-year follow-up of risk factors. Am J Epidemiol. 1985;121:563-569. (Pubitemid 15113097)
5. Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE. Employer burden ofmild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27:78-89.
6. Burgess DJ, Fu SS, Noorbaloochi S, et al. Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy. Nicotine Tob Res. 2009;11:1439-1447.
7. Burton WN, Chen CY, Schultz AB, Edington DW. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population. Popul Health Manag. 2010;13:1-8.
8. Burton WN, Conti DJ. Disability management: corporatemedical department management of employee health and productivity. J Occup Environ Med. 2000;42:1006-1012.
9. CarlsG, Li T, Panopalis P, Wang S, et al.Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis. J Occup Environ Med. 2009;51:66-79.
10. Chenoweth DH, Garrett J. Cost-effectiveness analysis of a worksite clinic: is it worth the cost? AAOHN J. 2006;54:84-89.
11. Disparity Reducing Advances (DRA) Project. The Biomonitoring Futures Project: Final Report and Recommendations. Available at: www.altfutures.com/bfp. Accessed March 30, 2007.
12. Franche RL, Severin CN, Hogg-Johnson S, Coté P, Vidmar M, Lee H. The impact of early workplace-based return-to-work strategies on work absence duration: a 6-month longitudinal study following an occupational musculoskeletal injury. J Occup Environ Med. 2007;49:960-974. (Pubitemid 47396322)
13. Goetzel RZ, Roemer EC, Short ME, et al. Health improvement from a worksite health promotion private-public partnership. J Occup Environ Med. 2009;51:296-304.
14. Goetzel RZ, Roemer EC, Pei X, et al. Second-year results of an obesity prevention program at the Dow Chemical Company. J Occup Environ Med. 2010;52:291-302.
15. Goetzel RZ, Carls GS, Wang S, et al. The relationship between modifiable health risk factors and medical expenditures, absenteeism, short-term disability, and presenteeism among employees at novartis. J Occup Environ Med. 2009;51:487-499.
16. Goetzel RZ, Baker KM, Short ME, et al. First-year results of an obesity prevention program at the Dow Chemical Company. J Occup Environ Med. 2009;51:125-138.
17. Goetzel RZ, Gibson TB, Short ME, et al. A multi-worksite analysis of the relationships among body mass index, medical utilization, and worker productivity. J Occup Environ Med. 2010;52:52-58.
18. Goetzel RZ, Ozminkowski RJ, Pelletier KR, Metz D, Chapman L. Emerging trends in Health and Productivity Management. Am J Health Promot. 2007;22:(suppl):1-7. (Pubitemid 350194759)
19. Goetzel RZ, Ozminkowski RJ, Baase CM, Billotti GM. Estimating the returnon- investment from changes in employee health risks on the Dow Chemical Companys health care costs. J Occup Environ Med. 2005;47:759-764.
20. Goetzel RZ, Ozminkowski RJ, Asciutto AJ, Chouinard P, Barrett M. Survey of Koop award winners: life-cycle insights. Art Health Promot (Am J Health Promot Suppl). 2001;5:2-8.
21. Goetzel RZ, Ozminkowski RJ, Bruno JA, Rutter KR, Isaac F, Wang S. The long-term impact of Johnson & Johnsons Health & Wellness Program on employee health risks. J Occup Environ Med. 2002;44:417-424. (Pubitemid 34507430)
22. Goetzel RZ, Ozminkowski RJ, Luisi D. Worksite Health Promotion: Public Private Partnerships RFA-CD-04-002, 1 R01 DP000096-01. Atlanta, GA: Centers for Disease Control and Prevention; 2004.
23. Goetzel RZ, Stapleton D, DeJoy D, Wilson M, Ozminkowski RJ. Environmental Approaches to Obesity Management at The Dow Chemical Company: National Heart Lung and Blood Institute RFA-HL-04-006. Sponsor Agreement ID: 1 R01 HL079546 2004.
24. Goetzel RZ. Essential building blocks for successful worksite health promotion programs. Manag Employ Health Bene. 1997;6:1-6.
25. Goetzel RZ. Senior Risk Reduction Demonstration (SSRD). Atlanta, GA: Centers for Medicare Medicaid Services (CMS); 2006. Available at: http://www.cms.gov/DemoProjectsEvalRpts/downloads/MasterSORList.pdf. Accessed September 29, 2011.
26. Haynes G, Dunnagan T. Comparing changes in health risk factors and medical costs over time. Am J Health Promot. 2002;17:112-121. (Pubitemid 35387966)
27. Heaney CA, Goetzel RZ. A review of health-related outcomes of multicomponent worksite health promotion programs. Am J Health Promot. 1997;11:290-307. (Pubitemid 27097512)
28. Henke RM, Carls GS, Short ME, et al. The relationship between health risks and health and productivity costs among employees at Pepsi Bottling Group. J Occup Environ Med. 2010;52:519-527.
29. Hilton MF, Whiteford HA. Associations between psychological distress, workplace accidents, workplace failures, and workplace successes. Int Arch Occup Environ Health. 2010;83:923-933.
30. Herman CW, Musich S, Lu C, Sill S, Young JM, Edington DW. Effectiveness of an incentive-based online physical activity intervention on employee health status. J Occup Environ Med. 2006;48:889-895. (Pubitemid 44394326)
31. Jordan N, Grissom G, Alonzo G, Dietzen L, Sangsland S. Economic benefit of chemical dependency treatment to employers. J Subst Abuse Treat. 2008;34:311-319. (Pubitemid 351337578)
32. Kimbrough EC, Pelletier K, Talamonti W. An integrative medicine intervention in a Ford Motor Company assembly plant. J Occup Environ Med. 2010;52:256-257.
33. Koehoorn M, Cole DC, Hertzman C, Lee H. Health care use associated with work-related musculoskeletal disorders among hospital workers. J Occup Rehabil. 2006;16:411-424. (Pubitemid 44411416)
34. Koopman C, Pelletier KR, Murray JF, et al. Stanford Presenteeism Scale: health status and employee productivity. J Occup Environ Med. 2002;44: 14-20. (Pubitemid 34052802)
35. Loeppke R, Nicholson S, Taitel M, SweeneyM, Haufle V, Kessler RC. The impact of an integrated population health enhancement and disease management program on employee health risk, health conditions, and productivity. Popul Health Manag. 2008;11:287-296.
36. Leutzinger JA, Ozminkowski RJ, Dunn RL, et al. Projecting health care costs using four scenarios of lifestyle risk rates. Am J Health Promot. 2008;11:35-44.
37. Lo Sasso AT, Rost K, Beck A. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach. Med Care. 2006;44:352-358. (Pubitemid 43755439)
38. Long AD, Sheehan P. A case study of population health improvement at a midwest regional hospital employer. Popul Health Manag 2010;13:1-11.
39. Long DA, Parry TL. An application of survival analysis to population health management program evaluation. Am J Health Promot. 2007;21:529-533. (Pubitemid 47067859)
40. Mattke S, Sexner SA, Zakowski SL, Jain AK, Gold DB. Impact of 2 employersponsored population health management programs on medical care cost and utilization. Am J Manag Care. 2009;15:113-120.
41. McGrew JH, Johannesen JK, Griss ME, Born DL, Katuin CH. Performancebased funding of supported employment for persons with severe mental illness: vocational rehabilitation and employment staff perspectives. J Behav Health Serv Res. 2007;34:1-16. (Pubitemid 46122501)
42. Merrill RM, Aldana SG. Improving overall health status through the CHIP intervention. Am J Health Behav. 2009;33:135-146.
43. Merrill RM, Aldana SG, Ellrodt G, Orsi R, Grelle-Laramee J. Efficacy of the Berkshire Health System Cardiovascular Health Risk Reduction Program. J Occup Environ Med. 2009;51:1024-1031.
44. Miller TR, Zaloshnja E, Spicer RS. Effectiveness and benefit-cost of peerbased workplace substance abuse prevention coupled with random testing. Accid Anal Prev. 2007;39:565-573. (Pubitemid 46659838)
45. Mills PR, Kessler RC, Cooper J, Sullivan S. Impact of a health promotion program on employee health risks andwork productivity. Am JHealth Promot. 2007;22:45-53. (Pubitemid 350194754)
46. Musich S, Napier D, Edington DW. The association of health risks with workers compensation costs. J Occup Environ Med. 2001;43:534-541. (Pubitemid 32522275)
47. Naydeck BL, Pearson JA, Ozminkowski RJ, Day BT, Goetzel RZ. The impact of the highmark employee wellness programs on 4-year healthcare costs. J Occup Environ Med. 2008;50:146-156. (Pubitemid 351321682)
48. ODonnell M, Bishop C, Kaplan K. Benchmarking best practices inworkplace health promotion. Art Health Promot. (Am J Health Promot Suppl). 1997;1: 1-8.
49. ODonnell MP. Health promotion advocates history and current focus. The art of health promotion. Am J Health Promot Suppl. 2005;1-12.
50. ODonnell MP. The rationale for federal policy to stimulate workplace health promotion programs. N C Med J. 2006;76:455-457.
51. Okechukwu CA, Krieger N, Sorensen G, Li Y, Barbeau EM. MassBuilt: effectiveness of an apprenticeship site-based smoking cessation intervention for unionized building trades workers. Cancer Causes Control. 2009;20:887-894.
52. Ozminkowski RJ, Goetzel RZ, Smith MW, Cantor RI, Shaughnessy A, Harrison M. The impact of the Citibank, NA, health management program on changes in employee health risks over time. J Occup Environ Med. 2000;42:502-511. (Pubitemid 30316966)
53. Ozminkowski RJ, Goetzel RZ, Wang F, et al. The savings gained from participation in health promotion programs for Medicare beneficiaries. J Occup Environ Med. 2006;48:1125-1132. (Pubitemid 44737083)
54. Pai CW, Mullin J, Payne GM, Love J, OConnell G, Edington DW. Factors associated with incidental sickness absence among employees in one health care system. Am J Health Promot. 2009;24:37-48.
55. Pai CW, Hagen SE, Bender J, Shoemaker D, Edington DW. Effect of health risk appraisal frequency on change in health status. J Occup Environ Med. 2009;51:429-434.
56. Parker KB, DeJoy DM, Wilson MG, Bowen HM, Goetzel RZ. Application of the Environmental Assessment Tool (EAT) as a process measure for a worksite weight management intervention. J Occup Environ Med. 2010;52: S42-51.
57. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1995-1995 update (IV). Am J Health Promot. 1999;13: 333-345. (Pubitemid 29386007)
58. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1998-2000 update. Am J Health Promot. 2001;16:107-116. (Pubitemid 33062649)
59. Pelletier KR. A review and analysis of the health and cost-effective outcomes studies of comprehensive health promotion and disease prevention programs. Am J Health Promot. 1991;5:311-313.
60. Pelletier KR. A review and analysis of the health and cost-effective outcome studies of comprehensive health promotion and disease prevention programs at the worksite: 1991-1993 update. Am J Health Promot. 1993;8:50-62. (Pubitemid 23297261)
61. Pelletier KR. A review and analysis of the health and cost-effective outcome studies of comprehensive health promotion and disease prevention programs at the worksite: 1993-1995 update. Am J Health Promot.1996;10:380-388. (Pubitemid 26152846)
62. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and diseasemanagement programs at the worksite: update VI: 2000-2004. J Occup Environ Med. 2005;47:1051-1058. (Pubitemid 41504814)
63. Pescatello LS, Murphy D, Vollono J, Lynch E, Bernene J, Costanzo D. The cardiovascular health impact of an incentive worksite health promotion program. Am J Health Promot. 2001;16:16-20. (Pubitemid 32862125)
64. Poole K, Kumpfer K, Pett M. The impact of an incentive-basedworksite health promotion program on modifiable health risk factors. Am J Health Promot. 2001;16:21-26. (Pubitemid 32862126)
65. Pratt CA, Lemon SC, Fernandez ID, et al. Design characteristics of worksite environmental interventions for obesity prevention. Obesity. 2007;15: 2171-2180. (Pubitemid 350004084)
66. Ramsey S, Summers KH, Leong SA, Birnbaum HG, Kemner JE, Greenberg P. Productivity and medical costs of diabetes in a large employer population. Diabetes Care. 2002;25:23-29. (Pubitemid 41070778)
67. Schultz AB, Edington DW. Metabolic syndrome in a workplace: prevalence, co-morbidities, and economic impact. Metab Syndr RelatDisord. 2009;7:459-468.
68. Schultz AB, Edington DW. The association between changes in metabolic syndrome and changes in cost in a workplace population. J Occup Environ Med. 2009;51:771-779.
69. Schultz AB, Lu CF, Barnett TE, et al. Influence of participation in a worksite health-promotion program on disability days. J Occup Environ Med. 2002;44:776-780.
70. Serxner S, Gold D, Anderson D, Williams D. The impact of a worksite health promotion program on short-disability usage. J Occup Environ Med. 2001;43:25-29. (Pubitemid 32101412)
71. Serxner S, Gold D, Grossmeier J, Anderson D. The relationship between health promotion program participation and medical costs: a dose response. J Occup Environ Med. 2003;45:1196-1200. (Pubitemid 37420865)
72. Sherman B. Worksite health promotion-A critical investment. Dis Manag Health Outcomes. 2002;10:101-108. (Pubitemid 34235000)
73. Stave G, Muchmore L, Gardner H. Quantifiable impact of the contract for health and wellness: health behaviors, health care costs, disability, and workers compensation. J Occup Environ Med. 2003;45:109-117. (Pubitemid 36228289)
74. Stein A, Shakour S, Zuidema R. Financial incentives, participation in employer-sponsored health promotion, and changes in employee health and productivity: HealthPlus Health Quotient Program. J Occup Environ Med. 2000;42:1148-1155. (Pubitemid 32014677)
75. Steenstra IA, Knol DL, Bongers PM, Anema JR, Van Mechelen W. What works best for whom? An exploratory, subgroup analysis in a randomized, controlled trial on the effectiveness of a workplace intervention in low back pain patients on return to work. Spine. 2009;34:1243-1249.
76. Sternfeld B, Block C, Quesenberry CP, et al. Improving diet and physical activity with ALIVE: a worksite randomized trial. Am J Prev Med. 2009;36: 475-483.
77. Stokols D, Pelletier K, Fieldings J. Integration of medical care and worksite health promotion. JAMA. 1995;273:1136-1142.
78. Stone B. Social networkings next phase. New York Times: March 3, 2007. Available at: http://www.nytimes.com/2007/03/03/technology/03social.html? ei=5090&en=f71af17a000673a4&ex=1330578000&adxnnl=0&partner= rssuserland&emc=rss&adxnnlx=1172938042-ykmcfkRFvjEqnR2pLPd9FA &pagewanted=all. Accessed March 30, 2007.
79. The 2029 Project-Achieving an ethical future for biomedical R&D. Institute for Alternative Futures. Available at: http://www.altfutures.com/pubs/ pharma/The%202029%20Report.pdf. Accessed March 30, 2007.
80. Tucker LA, Clegg AG. Differences in health care costs and utilization among adults with selected lifestyle-related risk factors. Am J Health Promot. 2002;16:225-233. (Pubitemid 34246535)
81. vanVonno CJ, Ozminkowski RJ, Smith MW, et al. What can a pilot congestive heart failure disease management program tell us about likely return on investment?: a case study from a program offered to federal employees. Dis Manag. 2005;8:346360.
82. Wang F, Schultz AB, Musich S, McDonald T, Hirschland D, Edington DW. The relationship between National Heart, Lung and Blood Institute Weight Guidelines and concurrent medical costs in a manufacturing population. Am J Health Promot. 2003;17:183-189. (Pubitemid 36091356)
83. Wasserman J, Whitmer RW, Bazarre RL, et al. Gender-specific effects ofmodifiable health risk factors on coronary heart disease and related expenditures. J Occup Env Med. 2000;42:1060-1069.
84. WELCOA: Wellness Councils of America. 2007. Seven benchmarks of success. Available at: http://www.welcoa.org/wellworkplace/index.php? category=2.
85. Whitmer RW, Pelletier KR, Anderson DR, Basse CM, Frost GJ. A wake-up call for corporate America. J Occup Environ Med. 2003;45:916-925. (Pubitemid 37140039)
86. Wild DM, Redlich CA, Paltiel AD. Surveillance for isocyanate asthma: a model based cost effectiveness analysis. Occup Environ Med. 2005;62:743-749. (Pubitemid 41565008)
87. Wright DW, Beard MJ, Edington DW. Association of health risks with the cost of time away from work. J Occup Environ Med. 2002;44:1126-1134. (Pubitemid 36024914)